Scopus Biopharma Inc. is a clinical-stage biopharmaceutical company dedicated to developing transformational therapeutics for serious diseases with significant unmet medical needs. The company's primary focus is on immuno-oncology, aiming to improve outcomes for patients with treatment-resistant cancers. Scopus Biopharma's innovative Duet Platform consists of a suite of bifunctional oligonucleotides that both activate antigen-presenting cells within the tumor microenvironment and relieve tumor-induced immunosuppression, thereby jump-starting T cell-mediated immune responses. The platform includes three candidates—DUET-01, DUET-02, and DUET-03—which combine a toll-like receptor 9 (TLR9) agonist with a STAT3 inhibitor, targeting various blood and solid tumors, including B-cell non-Hodgkin lymphoma and cancers such as prostate and kidney. Headquartered in New York and founded in 2017, Scopus Biopharma leverages collaborations and licensing agreements with leading research institutions to bring groundbreaking therapies from the laboratory to the clinic, positioning itself as a key innovator in the biopharmaceutical and immuno-oncology landscape.
Website420 Lexington Avenue
New York, NY, 10170
United States
Investors talking about SCPS also mention
What share of all stock conversation is about SCPS?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% new | 0% +0 |
Of the messages about SCPS that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | — | ||
| Bearish | — | — | — | — |
Of the messages about SCPS that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Analysts | — | — | — | — | ||
| Announcements | — | — | — | — | ||
| Controversies | — | — | — | — | ||
| Earnings | — | — | — | — | ||
| Macro | — | — | — | — | ||
| Technical Analysis | — | — | — | — |
Of the messages about SCPS, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 0% | 0% | 0% | 0% | ||
| Newcomers | 100% | 100% | 100% | 100% |